Cardiff Oncology, Inc. (CRDF) Financials

$4.26

south_east
-$0.08 (-1.84%)
Day's range
$4.24
Day's range
$4.63

CRDF Income statement / Annual

Last year (2023), Cardiff Oncology, Inc.'s total revenue was $488,000.00, an increase of 26.42% from the previous year. In 2023, Cardiff Oncology, Inc.'s net income was -$41.44 M. See Cardiff Oncology, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $488,000.00 $386,000.00 $359,000.00 $365,993.00 $245,000.00 $378,000.00 $505,000.00 $381,000.00 $313,000.00 $280,000.00
Cost of Revenue $0.00 $200,000.00 $500,000.00 $11.24 M $11.16 M $597,000.00 $1.81 M $1.73 M $629,000.00 $15,000.00
Gross Profit $488,000.00 $186,000.00 -$141,000.00 -$10.87 M -$10.92 M -$219,000.00 -$1.31 M -$1.35 M -$316,000.00 $265,000.00
Gross Profit Ratio 1 0.48 -0.39 -29.7 -44.56 -0.58 -2.59 -3.54 -1.01 0.95
Research and Development Expenses $32.86 M $27.11 M $17.38 M $11.24 M $11.16 M $8.16 M $7.88 M $15.01 M $10.59 M $6.67 M
General & Administrative Expenses $13.04 M $13.18 M $11.84 M $8.22 M $5.76 M $8.01 M $11.50 M $11.48 M $7.92 M $5.81 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $417.00 $2.74 M $11.52 M $6.44 M $2.74 M
Selling, General & Administrative Expenses $13.04 M $13.18 M $11.84 M $8.22 M $5.76 M $8.01 M $14.23 M $23.00 M $14.36 M $8.55 M
Other Expenses $0.00 -$383,000.00 $15,000.00 -$28,244.00 $2,000.00 -$237,000.00 -$170,000.00 -$145,000.00 -$3,000.00 $0.00
Operating Expenses $45.90 M $40.29 M $29.21 M $19.45 M $16.92 M $16.17 M $22.12 M $38.01 M $24.96 M $15.21 M
Cost And Expenses $45.90 M $40.29 M $29.21 M $19.45 M $16.92 M $16.77 M $23.93 M $39.74 M $25.59 M $15.23 M
Interest Income $4.07 M $1.58 M $264,000.00 $89,809.00 $234,169.00 $219,430.00 $147,883.00 $0.00 $57,261.00 $12,000.00
Interest Expense $0.00 $1.58 M $0.00 $1,519.00 $0.00 $25,409.00 $886,000.00 $1.38 M $1.53 M $843,000.00
Depreciation & Amortization $398,000.00 $200,000.00 $500,000.00 $466,009.00 $494,232.00 $736,088.00 $1.05 M $1.07 M $378,711.00 $234,813.00
EBITDA -$45.01 M -$39.67 M -$28.40 M -$18.84 M -$15.92 M -$15.70 M -$22.82 M -$36.76 M -$24.89 M -$14.71 M
EBITDA Ratio -92.24 -102.76 -79.91 -50.71 -66.17 -41.01 -44.24 -104.87 -78.43 -53.33
Operating Income Ratio -93.06 -103.37 -80.38 -52.15 -68.07 -45.11 -50.69 -105.37 -80.75 -53.38
Total Other Income/Expenses Net $3.97 M $1.20 M $564,000.00 -$220,672.00 $264,335.00 -$72,453.00 $689,053.00 $941,892.00 -$2.20 M $619,675.00
Income Before Tax -$41.44 M -$38.70 M -$28.29 M -$19.31 M -$16.41 M -$16.46 M -$24.91 M -$39.20 M -$27.47 M -$14.33 M
Income Before Tax Ratio -84.92 -100.27 -78.81 -52.75 -67 -43.55 -49.32 -102.9 -87.77 -51.16
Income Tax Expense $0.00 -$1.20 M -$549,000.00 -$26,725.00 -$262,000.00 $617,643.00 $716,000.00 -$296,000.00 $1.82 M $608,187.00
Net Income -$41.44 M -$37.51 M -$27.74 M -$19.28 M -$16.15 M -$16.46 M -$24.91 M -$39.20 M -$27.47 M -$14.33 M
Net Income Ratio -84.92 -97.17 -77.28 -52.68 -65.93 -43.55 -49.32 -102.9 -87.77 -51.16
EPS -0.93 -0.86 -0.71 -0.92 -2.7 -7.06 -51.71 -93.54 -75.49 -54.56
EPS Diluted -0.93 -0.86 -0.71 -0.92 -2.7 -7.06 -51.71 -93.22 -74.77 -54.08
Weighted Average Shares Out $44.68 M $43.60 M $39.03 M $20.87 M $5.97 M $2.33 M $481,665.00 $419,096.00 $363,915.00 $262,555.00
Weighted Average Shares Out Diluted $44.68 M $43.60 M $39.03 M $20.87 M $5.97 M $2.33 M $481,665.00 $420,568.00 $367,388.00 $264,874.00
Link